158 related articles for article (PubMed ID: 11979429)
1. Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma.
Nakanishi H; Araki N; Kudawara I; Kuratsu S; Matsumine A; Mano M; Naka N; Myoui A; Ueda T; Yoshikawa H
Int J Cancer; 2002 May; 99(2):167-70. PubMed ID: 11979429
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis.
Le Doussal V; Coindre JM; Leroux A; Hacene K; Terrier P; Bui NB; Bonichon F; Collin F; Mandard AM; Contesso G
Cancer; 1996 May; 77(9):1823-30. PubMed ID: 8646680
[TBL] [Abstract][Full Text] [Related]
4. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
[TBL] [Abstract][Full Text] [Related]
5. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
7. Results of surgery for malignant fibrous histiocytomas of soft tissue.
Matsumoto S; Ahmed AR; Kawaguchi N; Manabe J; Matsushita Y
Int J Clin Oncol; 2003 Apr; 8(2):104-9. PubMed ID: 12720103
[TBL] [Abstract][Full Text] [Related]
8. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
10. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer.
Omae K; Kondo T; Tanabe K
Urol Oncol; 2015 Feb; 33(2):67.e9-13. PubMed ID: 25130069
[TBL] [Abstract][Full Text] [Related]
11. Preoperative elevation of serum C-reactive protein as an indicator of poor prognosis for early-stage esophageal squamous cell carcinoma.
Song ZB; Lin BC; Li B; He CX; Zhang BB; Shao L; Zhang YP
Kaohsiung J Med Sci; 2013 Dec; 29(12):662-6. PubMed ID: 24296054
[TBL] [Abstract][Full Text] [Related]
12. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas.
Engellau J; Anderson H; Rydholm A; Bauer HC; Hall KS; Gustafson P; Akerman M; Meis-Kindblom J; Alvegård TA; Nilbert M;
Cancer; 2004 May; 100(10):2233-9. PubMed ID: 15139069
[TBL] [Abstract][Full Text] [Related]
13. Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children's Research Hospital experience.
Daw NC; Billups CA; Pappo AS; Jenkins JJ; Mahmoud HH; Krasin MJ; Rao BN
Cancer; 2003 Jun; 97(11):2839-47. PubMed ID: 12767098
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.
Chang CC; Sun CF; Pai HJ; Wang WK; Hsieh CC; Kuo LM; Wang CS
Chang Gung Med J; 2010; 33(3):301-12. PubMed ID: 20584508
[TBL] [Abstract][Full Text] [Related]
15. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
[TBL] [Abstract][Full Text] [Related]
16. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Ohtsuka Y; Fujii Y; Masuda H; Kumagai J; Kobayashi T; Kageyama Y; Kihara K
BJU Int; 2007 Aug; 100(2):269-73. PubMed ID: 17488302
[TBL] [Abstract][Full Text] [Related]
17. [Malignant fibrous histiocytoma of the soft tissues].
Fedenko AN; Blinov VM; Solov'ev IuN
Arkh Patol; 1985; 47(9):20-8. PubMed ID: 3000323
[TBL] [Abstract][Full Text] [Related]
18. The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.
Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
Tumour Biol; 2015 Sep; 36(10):7515-20. PubMed ID: 25913621
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M
Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372
[TBL] [Abstract][Full Text] [Related]
20. Treatment results and prognostic factors in patients with malignant fibrous histiocytoma.
Hsu HC; Huang EY; Wang CJ
Acta Oncol; 2004; 43(6):530-5. PubMed ID: 15370609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
